BSS

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
BSS
Generic name
BALANCED SALT SOLUTION
Manufacturer
Alcon Laboratories, Inc.
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea
SPL ID
f56f90e2-cd68-445b-b8fb-74a53f0f2ca6
Version
15
Effective date
2024-01-25
Source export date
2026-09-28
Source partition
14
Source file
https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:40:26
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS • NOT FOR INJECTION OR INTRAVENOUS INFUSION. • Do not use unless product is clear, seal is intact, and container is undamaged. • Do not use if product is discolored or contains a precipitate. • SINGLE patient use only. The contents of this bottle should not be used in more than one patient. • This solution contains no preservative, unused contents should be discarded.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS Irrigation or any other trauma to the corneal endothelium may result in corneal swelling or bullous keratopathy. Post-operative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.